Compared to colonoscopy, blood-based tumor biomarkers such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19–9 (CA19-9), are widely used because they are noninvasive but show unsatisfactory performance [4]. Here, CEACAM5 is linked to neoplasm.